"Only valence theory" of the drug pricing model makes medicine enterprises difficult to juggle the drug quality, don't even willing to red, and finally let batch production of cheap from pharmacy shelves commonly disappear. Along with the national development and reform commission the 27th wheel reduction to implement formally a few days ago, the brand is what difficulties facing proprietary Chinese medicine enterprise exactly? Please attention this focus --

Brand proprietary Chinese medicine trapped "all siege"

The national development and reform commission the 27th wheel reduction to implement formally a few days ago. In the National People's Congress to represent the have called on abandoned drugs "only price theory", this round after the promulgation of and implementing the price again to touch market sensitive nerve.

In this year's two meetings, Chinese herbal medicine prices, proprietary Chinese medicine decline in margins, causing "fake" qualified the problems caused by the National People's Congress, great attention. National People's Congress to represent one after another for medicine, zhong nanshan devoted himself CengQingHong ten-thousand-enterprise utterance: medicine industry will face raw materials, energy, artificially, rents higher difficulty. And because of drug impose price controls state, coupled with the government to release, drug price fixing prices and not like other industries with rising costs and rise. "Only valence theory" of the drug pricing model makes medicine enterprises difficult to juggle the drug quality, don't even willing to red, and finally let batch production of cheap from pharmacy shelves commonly disappear.

Proprietary Chinese medicine production cost is as NPC said steeply? Production deficit to still earn exactly is proprietary Chinese medicines? What exactly face brand proprietary Chinese medicine enterprise dilemma? To understand the real living situation of proprietary Chinese medicine, in recent days, "yangcheng evening news" way of questionnaire to guangdong dozen proprietary Chinese medicine production enterprises' investigation.

Chinese herbal medicine, pharmaceutical prices declining profits

Since 2009, from mainly in Chinese herbal medicine price production costs have dogged the proprietary Chinese medicine industry.

In this year's two meetings of National People's Congress on the cardiovascular drugs mentioned DanCanPian compound as an example, CengQingHong survey of National People's Congress, its main raw material sanqi (panax notoginseng), originally is 60 yuan/kg, the year before is 100 yuan/kg, last January rise to 200 yuan/kg, march of last year the price but also soared to 360 yuan/kg, highest when actually reach 600 yuan one kilogram, more than one year's time rose nearly 10 times.

In fact, not only is sanqi (panax notoginseng), since last year, due to natural disasters, part of Chinese herbal medicine production affect greatly decreased, but at the same time, the market demand is unabated, plus the hype, and government liquidity of Chinese materia medica price oversight weak, mechanism, the domestic most Chinese herbal medicine prices are rising in different range.

Guangdong is the proprietary Chinese medicine production and consumption of important Chinese provinces. In this questionnaire, respondents for enterprise to produce angelica, liquorice, balloonflower, friyzllaria ussuriensis, water sprouting, dangshen, radix scutellariae, xiong, root in Chinese, honeysuckle etc are among the list price. Almost a year nine into production costs of enterprise polled the largest increase 20%, which is the Chinese herbal medicine. 7 become the core products required interviewed enterprise of Chinese medicinal materials prices 10% ~ 50% of respondents, and three Chinese enterprise's core products required the prices more than 100%.

And Chinese medicine association offers a data also show: the 2010 national market 537 kind of Chinese herbal medicine 84 percent rise in price, more than 5% ~ 180%of. Among them, 28% of Chinese herbal medicine prices rose more than 51 percent, 6 percent more than 181%, 2% more than 300%. Participate in the most obvious increase prince, since early 2010 353% rise reach.

Chinese herbal medicine prices soar greatly reduces the proprietary business profit margins. In this survey respondents, with 80 percent year-on-year sales companies say proprietary gross margin, even dropped unprofitable. From the listed company already disclosed the proprietary Chinese medicine pharmaceutical business situation, although 2010 net profit has realized different amplitude growth, but raw material costs or lead to a company profitability dropped.

Price cut prices to come on stage, raised hopeless

Although raw materials, artificial, energy utilities and other costs continue to rise, but for the price of drugs, according to the national way of supervision, cost rises from contradictory but difficult to fully passed on to the price of product.

Instead, in October 2009 "issued by the national development and reform commission (NDRC published for the first time about the state's basic drugs retail guiding price notice (hair [2009] 2489 change price).", the base medicine published with the current government stipulated price than retail pricing, about 45% of the variety price cut, the average price cut appropriately to around 12%. And basic drugs system implementation, the pilot area after basic drugs and actual retail prices declined 30%, part pilot areas by up 50%. The above 60 pieces of the list, the DanCanPian compound specifications by 7.2 yuan and guided prices further down to 6.6 yuan.

And it was at base medicine retail pricing released a year later, in November 2010 and 2011 March the national development and reform commission twice wield depreciate broadsword, reduce 180 many kinds of retail price and highest drug price drop for 20% average twice. So far, the national development and reform commission issued 27 to one of the greatest reduction, zhang an average drop of 40%.

In this questionnaire, 90 percent of respondents enterprise's product had ranging from 1% ~ 50% of the price. In raw material costs of rising prices, many respondents enterprise reflects the highest retail price, currently released time is too long, that needs to be making the highest retail prices, not proprietary price blindly, but should be based on the raw materials, labor costs such as comprehensive factors, in a year or about half a year fixed time announced a price.

Ultra low-cost competition, inferior drugs expel medicine

Besides Chinese herbal medicine price, national policy, the influence of such from outside the ultra low-cost competition, peer NanYanZhiYin proprietary Chinese medicine "is the brand".

DanCanPian this species in compound, the author recently visited guangzhou city several drugstore, different manufacturers to see the 60 pieces DanCanPian price uneven installed compound. The same specifications, as the nation's largest compound DanCanPian production enterprise baiyun mountain and yellow retails for $6, and guangdong another call satisfying kang medicine enterprises producing retail price of to 3.7 yuan only. Then the author in a qualified pharmaceutical trade globaltext.org, the former price of goods for 5.62 yuan, while the latter price of goods is only $1.05. That is, if the former drugstore sells 6 yuan only, if only 6% of pharmacy profit space, but if sales the latter case, retail price although low to 3.7 yuan, but a pharmacy profit space but up to 88%.

But congress, if CengQingHong investigation found on the current market 360 yuan/kg of notoginseng with pharmacopoeial requirements production calculation, a bottle of 60 pieces of compound DanCanPian, 371 installed a cost will account for 3 yuan, don't say and danshen, borneol, auxiliary materials, artificial etc cost. A bottle of 60 pieces of compound DanCanPian only $1.05 supply price, its quality really worrying.

In November 2010 YaoJianSuo in hebei province of hebei province, the administration's and combination of ten several brand province sales for sampling inspection, found DanCanPian compound qualified only baiyun mountain and yellow wait for two brands. But 2010 jiangsu released the first issue of drug quality bulletin, two manufacturers were detected DanCanPian compound organic, and there will be opposite the compound DanCanPian satisfying kang production.

A personage inside course of study tells the author, heterosexual organic refers to mix in medical illegal standard other similar materials, or the same plants in other parts of the traditional Chinese medicine outside. Anyway, detection is to identify enterprise heterosexual organic is to extract or baking powder into medicinal slice. "Because the current drug quality standard cannot fully reflect the quality of drugs, especially the proprietary Chinese medicine prescription several or dozens of medicinal herbs, but content index or identify only check parts of medicinal herbs, cannot reflect the whether prescription feeding. Therefore, many brand proprietary Chinese medicine are facing similar jerry product low-cost malignant competition".

But in the author in a questionnaire, the surveyed all enterprise reflected encounter similar products ultra low-cost competition, and the competition is fierce.

Bidding only price theory, forced to pull out the tender

In our country, the two into drug sales in drugstores, 80 percent of sales in the hospital. But even if is not to exceed the highest pricing formulated development, also does not mean that drug can smoothly into a hospital. Due to the similar product ultra low-cost competition, bidding became instead many brand proprietary Chinese medicine insuperable one line. A enterprise questioned in the whole nation at present popularization, the base medicine bidding "double envelope" system, one is economic and technical bid, the other is a commercial tender, but almost all pharmaceutical producing enterprises can satisfy "economic and technical bid" requirement, finally only by "the lowest price" factors.

Again with 60 pieces of compound as an example DanCanPian installed. The CPPCC national committee liu innovation in the basic drugs about appealed to adjust to public bidding proposal "the emergency, said the proposal in anhui province in the bidding process, basic drugs DanCanPian 60 pieces outfit sugar compound only 0.95 yuan/bottle, and domestic mainstream advantage enterprises with the product's market sales price of 5.6 yuan/bottle, prices vary nearly six times.

Last month by China pharmaceutical enterprise management association and jointly sponsored 20 association of medical forum, nearly 40 from NPC and CPPCC national committee members said, and medicine bidding only low-cost theory, the scale medicine enterprises in dilemma. Step length pharmaceutical group more than 20 basic drug varieties, because many drug bidding price basically could not reach cost, so step length pharmaceutical group but quit many provinces only the basic drugs bidding. And participated in many provinces bidding chen-kung pharmaceutical, also found that after technical threshold non-existing, because all basically the enterprise can through technology standard, so, the final competition remains basically competitive price. Currently furen pharmaceutical adopted measures is the price can satisfy the cost as bid, a look at the red hurried to nullify label. (LiuZhiLin LiRui)